{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T06:57:15Z","timestamp":1769237835246,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T00:00:00Z","timestamp":1222473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12325-008-0105-2","type":"journal-article","created":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T13:23:57Z","timestamp":1222521837000},"page":"1019-1030","source":"Crossref","is-referenced-by-count":54,"title":["Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial Inflammation"],"prefix":"10.1007","volume":"25","author":[{"given":"Roberto","family":"Dal Negro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Micheletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Tognella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilia","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Turati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,27]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"K.F. Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Diseas Pawels. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532\u2013555.","journal-title":"Am J Respir Crit Care Med."},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1378\/chest.117.1.1","volume":"117","author":"S. Ilurd","year":"2000","unstructured":"Ilurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117:1\u20134.","journal-title":"Chest"},{"issue":"suppl.2","key":"105_CR3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1378\/chest.117.5_suppl_2.380S","volume":"117","author":"S. Sethi","year":"2000","unstructured":"Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000;117(suppl. 2):380\u2013385.","journal-title":"Chest."},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"T.A.R. Seemungal","year":"1998","unstructured":"Seemungal TAR, Donaldson GC, Paul EA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418\u20131422.","journal-title":"Am J Respir Crit Care Med."},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","volume":"124","author":"K.H. Groenewegen","year":"2003","unstructured":"Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortalityrelated factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459\u2013467.","journal-title":"Chest."},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1034\/j.1399-3003.1999.13b20.x","volume":"13","author":"E. Monso","year":"1999","unstructured":"Monso E, Rossel A, Bonet G. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J. 1999;13:338\u2013342.","journal-title":"Eur Respir J."},{"issue":"suppl.C","key":"105_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0954-6111(03)80024-0","volume":"97","author":"R.W. Negro Dal","year":"2003","unstructured":"Dal Negro RW, Rossi A, Cerveri I. The burden of COPD in Italy: results from the confronting COPD survey. Respir Med. 2003;97(suppl. C):43\u201350.","journal-title":"Respir Med."},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/COPD.S671","volume":"3","author":"R. Negro Dal","year":"2008","unstructured":"Dal Negro R. Optimizing economic outcomes in the management of COPD. Int J COPD. 2008;3:1\u201310","journal-title":"Int J COPD."},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1378\/chest.121.5.1449","volume":"121","author":"M. Miravitlles","year":"2002","unstructured":"Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121:1449\u20131455.","journal-title":"Chest."},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.rmed.2007.08.001","volume":"102","author":"R.W. Negro Dal","year":"2008","unstructured":"Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (Social Impact of Respiratory Integrated Outcomes). Respir Med. 2008;102:92\u2013101.","journal-title":"Respir Med."},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/thorax.58.1.73","volume":"58","author":"A.J. White","year":"2003","unstructured":"White AJ, Gompertz S, Stocley RA. Chronic obstructive pulmonary disease 6: the aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax. 2003;58:73\u201380.","journal-title":"Thorax."},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/srin.2000.0150001","volume":"15","author":"R. Wilson","year":"2000","unstructured":"Wilson R, Grossman R. Introduction: the role of bacteria infection in chronic bronchitis. Semin Respir Infect. 2000; 15:1\u20136.","journal-title":"Semin Respir Infect."},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00019048-199812005-00004","volume":"7","author":"S. Sethi","year":"1998","unstructured":"Sethi S. Management of acute exacerbations of chronic bronchitis. Infect Dis Clin Pract. 1998;7:300\u2013308.","journal-title":"Infect Dis Clin Pract."},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1378\/chest.118.6.1557","volume":"118","author":"S. Sethi","year":"2000","unstructured":"Sethi S, Muscarella K, Evans N. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest. 2000;118:1557\u20131565.","journal-title":"Chest."},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.118.1.193","volume":"118","author":"J.V. Hirschmann","year":"2000","unstructured":"Hirschmann JV. Do bacteria cause exacerbation of COPD? Chest. 2000;118:193\u2013203.","journal-title":"Chest."},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","volume":"57","author":"I.S. Patel","year":"2002","unstructured":"Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57: 759\u2013764.","journal-title":"Thorax."},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000087686","volume":"73","author":"N. Lechtzin","year":"2006","unstructured":"Lechtzin N, John M, Irizarry R, Merlo C, Diette GB, Boyle M. Outcomes of adults with cystic fibrosis infected with antibioticresistant Pseudomonas aeruginosa. Respiration. 2006;73:27\u201333.","journal-title":"Respiration."},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thorax.56.9.669","volume":"56","author":"E. Caballero","year":"2001","unstructured":"Caballero E, Drobnic ME, P\u00e9rez MT, Manresa JM, Orriols R. Anti-Pseudomonas aerugionosa antibody detection in patients with bronchiectasis without cystic fibrosis. Thorax. 2001;56:669\u2013674.","journal-title":"Thorax."},{"key":"105_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1081\/COPD-200050680","volume":"2","author":"R.W. Negro Dal","year":"2005","unstructured":"Dal Negro RW, Micheletto C, Tognella S, Visconti M, Guerriero M, Sandri MF. A two-stage logistic model based on the measurement of proinflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations. COPD. 2005;2:7\u201316.","journal-title":"COPD."},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","volume":"177","author":"T.F. Murphy","year":"2008","unstructured":"Murphy TF, Brauer AL, Eschberger K, et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:853\u2013860.","journal-title":"Am J Respir Crit Care Med."},{"key":"105_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1378\/chest.122.1.219","volume":"122","author":"D.E. Geller","year":"2002","unstructured":"Geller DE, Pitlick W, Nardella PA, Tracewell W, Ransey BW. Pharmacokinetics and bioavailability of aerosolized Tobramycin in cystic fibrosis. Chest. 2002;122:219\u2013226.","journal-title":"Chest."},{"key":"105_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","volume":"162","author":"A.F. Barker","year":"2000","unstructured":"Barker AF, Fiel SB, Gotfried MH, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000;162:481\u2013485.","journal-title":"Am J Respir Crit Care Med."},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"N.R. Anthonisen","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Warren CP. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196\u2013204.","journal-title":"Ann Intern Med."},{"key":"105_CR24","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511527104","volume-title":"Cowan and Steel\u2019s Manual for the Identification of Medical Bacteria","author":"G.I. Barrow","year":"1993","unstructured":"Barrow GI, Feltman RK. Cowan and Steel\u2019s Manual for the Identification of Medical Bacteria. 3rd edition. Cambridge: Cambridge University press; 1993.","edition":"3rd edition"},{"key":"105_CR25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1515\/CCLM.1999.092","volume":"37","author":"F. Berthier","year":"1999","unstructured":"Berthier F, Lambert C, Genin C, Bienvenu J. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med. 1999;37:593\u2013599.","journal-title":"Clin Chem Lab Med."},{"key":"105_CR26","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1183\/09031936.94.07122109","volume":"7","author":"O.A. Khair","year":"1994","unstructured":"Khair OA, Devalia JL, Abdelaziz MM, et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. Eur Respir J. 1994;7:2109\u20132116.","journal-title":"Eur Respir J."},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9343(00)00507-6","volume":"109","author":"A.T. Hill","year":"2000","unstructured":"Hill AT, Campbel EJ, Hill SL. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000;109:288\u2013295.","journal-title":"Am J Med."},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1183\/09031936.99.14510159","volume":"14","author":"N. Soler","year":"1999","unstructured":"Soler N, Ewing S, Torres A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015\u20131022.","journal-title":"Eur Respir J."},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09629359990496","volume":"8","author":"A.L. Pukhalsky","year":"1999","unstructured":"Pukhalsky AL, Kapranov NI, Kalashnikova EA. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Mediators Inflamm. 1999;8: 159\u2013167.","journal-title":"Mediators Inflamm."},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dki179","volume":"56","author":"M.O. Husson","year":"2005","unstructured":"Husson MO, Wizla-Derambure N, Turck D, Gosset P, Wallaert B. Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis. J Antimicrob Chemother. 2005;56:247\u2013249.","journal-title":"J Antimicrob Chemother."},{"key":"105_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thorax.55.2.114","volume":"55","author":"A. Bhowmik","year":"2000","unstructured":"Bhowmik A, Seemugal TAR, Sapsford RJ. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55: 114\u2013120.","journal-title":"Thorax."},{"key":"105_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","volume":"39","author":"M.E. Drobnic","year":"2005","unstructured":"Drobnic ME, Sun\u00e9 P, Montoro JB, Ferrer A, Orriols R. Inhaled Tobramycin in noncystic fibrosis patients with bronchiectasis and chronic bronchial infection with pseudomonas aeruginosa. Ann Pharmacother. 2005;39:39\u201344.","journal-title":"Ann Pharmacother."},{"key":"105_CR33","first-page":"1420","volume":"127","author":"P. Scheinberg","year":"2005","unstructured":"Scheinberg P, Shore E. A pilot study of the safety and efficacy of Tobramycin solution for inhalation in patients with severe bronchiectasis. Chest. 2005;127:1420\u20131426.","journal-title":"Chest."},{"key":"105_CR34","first-page":"158","volume":"6","author":"J.S. Olowite","year":"1991","unstructured":"Olowite JS, Niederman MS, Fein AM. Delivery of topical antibiotics: pharmacokinetics and clinical problem. Semin Respir Infect. 1991;6:158\u2013167.","journal-title":"Semin Respir Infect."},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/adc.75.6.498","volume":"75","author":"D.Y. Koller","year":"1996","unstructured":"Koller DY, Gotz M, Wojnarowski C, Eichler I. Relationship between disease severity and inflammation markers in cystic fibrosis. Arch Dis Child. 1996;75:498\u2013501.","journal-title":"Arch Dis Child."}],"updated-by":[{"DOI":"10.1007\/s12325-008-0131-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T00:00:00Z","timestamp":1229990400000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-008-0105-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-008-0105-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:55:52Z","timestamp":1559462152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-008-0105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,27]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s12325-008-0105-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12325-008-0131-x","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,27]]}}}